"Nov. 18, 2012 -- Researchers say they've been able to use nanoparticles to stop multiple sclerosis (MS) in mice that are bred to have the disease.
The particles are about 200 times smaller than the thickness of a human hair. They are "...
There is no experience regarding teriflunomide overdose or intoxication in humans. Teriflunomide 70 mg daily up to 14 days was well tolerated by healthy subjects.
AUBAGIO is contraindicated in/with:
- Patients with severe hepatic impairment [see WARNINGS AND PRECAUTIONS].
- Pregnant women and females of reproductive potential not using effective contraception. AUBAGIO may cause fetal harm [see WARNINGS AND PRECAUTIONS and Use In Specific Populations].
- Patients with a history of a hypersensitivity reaction to teriflunomide, leflunomide, or to any of the inactive ingredients in AUBAGIO. Reactions have included anaphylaxis, angioedema, and serious skin reactions [see WARNINGS AND PRECAUTIONS].
- Coadministration with leflunomide [see CLINICAL PHARMACOLOGY].
Last reviewed on RxList: 12/12/2016
Additional Aubagio Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.